Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.77B P/E 42.01 EPS this Y - Ern Qtrly Grth -7.10%
Income 88.91M Forward P/E - EPS next Y - 50D Avg Chg -
Sales 1.25B PEG - EPS past 5Y - 200D Avg Chg 20.00%
Dividend 1.00% Price/Book 3.60 EPS next 5Y - 52W High Chg -
Recommedations - Quick Ratio 1.80 Shares Outstanding 251.88M 52W Low Chg 74.00%
Insider Own 0.34% ROA 4.91% Shares Float 250.86M Beta 0.65
Inst Own 59.32% ROE 8.98% Shares Shorted/Prior -/- Price 14.79
Gross Margin 32.56% Profit Margin 7.13% Avg. Volume 1,858 Target Price -
Oper. Margin 11.12% Earnings Date - Volume 49,618 Change 0.00%
About UDG HEALTHCARE PLC

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is headquartered in Dublin, the Republic of Ireland. As of August 16, 2021, UDG Healthcare plc was taken private.